本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

曼恩凯德生物医疗

3.52
+0.09002.62%
盘后3.520.00000.00%16:36 EDT
成交量:359.24万
成交额:1,263.75万
市值:10.80亿
市盈率:32.53
高:3.59
开:3.45
低:3.45
收:3.43
52周最高:7.63
52周最低:3.40
股本:3.07亿
流通股本:3.01亿
量比:0.85
换手率:1.19%
股息:- -
股息率:- -
每股收益(TTM):0.1082
每股收益(LYR):0.1005
净资产收益率:32.74%
总资产收益率:10.63%
市净率:-19.62
市盈率(LYR):35.01

数据加载中...

2024/02/27

重要事件披露

Form 8-K - Current report
2024/02/13

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/01/02

重要事件披露

Form 8-K - Current report
2023/12/28

重要事件披露

Form 8-K - Current report
2023/12/15

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/12/15

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/12/15

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/11/08

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/11/08

重要事件披露

Form 8-K - Current report
2023/11/01

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/10/03

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/09/01

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/08/28

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/08/24

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2023/08/07

重要事件披露

Form 8-K - Current report
2023/08/07

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/08/01

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/07/03

重要事件披露

Form 8-K - Current report
2023/07/03

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/06/01

关联方拟减持公告

Form 144 - Report of proposed sale of securities